Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer

  1. Camidge, D.R.
  2. Kim, H.R.
  3. Ahn, M.-J.
  4. Yang, J.C.-H.
  5. Han, J.-Y.
  6. Lee, J.-S.
  7. Hochmair, M.J.
  8. Li, J.Y.-C.
  9. Chang, G.-C.
  10. Lee, K.H.
  11. Gridelli, C.
  12. Delmonte, A.
  13. Garcia Campelo, R.
  14. Kim, D.-W.
  15. Bearz, A.
  16. Griesinger, F.
  17. Morabito, A.
  18. Felip, E.
  19. Califano, R.
  20. Ghosh, S.
  21. Spira, A.
  22. Gettinger, S.N.
  23. Tiseo, M.
  24. Gupta, N.
  25. Haney, J.
  26. Kerstein, D.
  27. Popat, S.
  28. Show all authors +
Journal:
New England Journal of Medicine

ISSN: 1533-4406 0028-4793

Year of publication: 2018

Volume: 379

Issue: 21

Pages: 2027-2039

Type: Article

DOI: 10.1056/NEJMOA1810171 GOOGLE SCHOLAR

Sustainable development goals